Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction.
about
Preeclampsia: long-term consequences for vascular healthRole of endothelin in uteroplacental circulation and fetal vascular functionCytokines as key players in the pathophysiology of preeclampsiaPathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiologyPreeclampsia, hypoxia, thrombosis, and inflammationAngiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyondIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesRole of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant ratsComplement activation is critical for placental ischemia-induced hypertension in the rat.Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.Endothelial dysfunction and arterial stiffness in pre-eclampsia demonstrated by the EndoPAT method.Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia.A new mouse model to explore therapies for preeclampsia.Vascular and cellular calcium in normal and hypertensive pregnancyRisk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.Effective prediction of preeclampsia by measuring serum angiotensin II, urinary angiotensinogen and urinary transforming growth factor β1.Differential gene expression analysis of placentas with increased vascular resistance and pre-eclampsia using whole-genome microarraysPregnancy-induced hypertension is accompanied by decreased number of circulating endothelial cells and circulating endothelial progenitor cells.Maternal plasma soluble TRAIL is decreased in preeclampsia.Progesterone supplementation attenuates hypertension and the autoantibody to the angiotensin II type I receptor in response to elevated interleukin-6 during pregnancy.Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsiaThe anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia.Effects of pregnancy, hypertension and nitric oxide inhibition on rat uterine artery myogenic reactivityAntihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia.Maternal Serum Lipids in Women with Pre-eclampsia.Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaaPlasma from preeclamptic women increases blood-brain barrier permeability: role of vascular endothelial growth factor signaling.The heme oxygenases: important regulators of pregnancy and preeclampsiaRecent insights into the pathophysiology of preeclampsia.Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants.Lipid peroxidation is not associated with adipocytokines in preeclamptic womenMaternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant womenEndothelin-1 is not a Mechanism of IL-17 Induced Hypertension during Pregnancy.Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.Brain cell apoptosis and enhancement of nervous excitability in pregnant rats with high plasma levels of homocysteineErythrocyte sodium/potassium ATPase activity in severe preeclampsia.Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance.Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension.
P2860
Q26800272-A634F350-6C82-43B7-BA60-6C630DDFA6A5Q26828020-6FE866C0-4018-4940-9BCA-C895C6F23C3AQ26830707-0C39ADD1-5B4F-4237-8EB0-4F727102527CQ26865332-40594E8C-07DD-4945-8632-932B5E1CB2A1Q27000388-7083EE46-E4D0-4B82-B89D-8D8C03E360D0Q27027039-B8DFF4CD-A6F0-45E1-9E37-2CBF4B37D7B6Q28388335-01D88303-0FE2-4AD4-A439-912507B8161AQ28571017-10044AB8-DB0C-460E-A5D7-891B4D50CD11Q30409861-E12E00CA-E91D-4029-AB21-E55E83CCF5E0Q33349894-E7CBC49B-6F4E-440F-B7F2-0818A492F9FEQ33652732-03718B46-AAD2-47C5-AD05-1C51C916943EQ33666742-1977305B-6D4D-4293-9B72-DC3C9F107D0CQ33668328-16788F7F-1937-4986-8EDD-4B1E9522D8E6Q33737551-E7F3CE42-7E8F-4BDA-AB3E-257612E3EE75Q33781354-9D371252-FACB-4F22-99AC-D43D889B6310Q33793455-DD4FC698-3157-4AE6-8312-3586B8AC49A0Q33799413-DF963DAB-5441-4203-8BA3-2831A0097D7EQ33847163-5B75012A-CE6F-406F-B723-E25ED5AF5951Q33872123-90137CE8-6C98-43C6-A600-6AEC0FA2C810Q33883127-293F8B3D-D2DB-4077-B620-4539A6956995Q33909572-B67CB2A4-1145-42B2-89B4-31C5632A4820Q33983395-C66F48EE-8CE8-4604-95C3-0219DA9AD1B4Q34140082-148EC108-1F46-41E6-9354-F985AC825511Q34150192-990C625B-B9E0-47D1-B85E-C15D6249F119Q34154020-E3248126-1F33-4908-8150-B782C900CAA3Q34154805-9F69B247-7DF9-48D7-874C-E2DAF784B4FDQ34162448-DB27310B-DFB7-4B22-B0C0-41295062F8DDQ34182374-FD62494A-BF2A-41EB-9455-B917BA8766EFQ34222231-0F787CDE-A036-4218-83F1-A2BB681AE79FQ34295822-D5F4E0BB-224E-4844-825F-E3DD4DB092E1Q34404445-5C1AD257-04D6-4247-8660-2615D7FD6E9EQ34429164-0D56201C-0A14-43E7-93B6-4EAB9CF10BA7Q34436853-6F0511FA-243F-474A-828D-223B0C9E361CQ34495512-1AF8B810-C37D-439F-826E-D3599025D4F1Q34533218-46537AD8-008E-42C9-A449-05A80B1453AAQ34619975-AFFF8AFA-4B0F-4474-9340-D137AAC288B3Q34720155-AEF431A7-E58C-47FA-895F-D0036B5C4BE7Q34727850-9D798293-7D19-40AE-B9AE-B6A156FB0BC6Q34772464-500D072A-5A0E-4193-89D9-CBF84D3F6BCFQ34904184-DCD19EA9-C6E9-4631-8A3C-FB4690A8A52E
P2860
Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Pathophysiology of hypertensio ...... with endothelial dysfunction.
@en
Pathophysiology of hypertensio ...... with endothelial dysfunction.
@nl
type
label
Pathophysiology of hypertensio ...... with endothelial dysfunction.
@en
Pathophysiology of hypertensio ...... with endothelial dysfunction.
@nl
prefLabel
Pathophysiology of hypertensio ...... with endothelial dysfunction.
@en
Pathophysiology of hypertensio ...... with endothelial dysfunction.
@nl
P2093
P2860
P921
P1476
Pathophysiology of hypertensio ...... with endothelial dysfunction.
@en
P2093
Babbette B LaMarca
Jeffrey S Gilbert
Joey P Granger
Michael J Ryan
Mona Sedeek
Sydney R Murphy
P2860
P304
P356
10.1152/AJPHEART.01113.2007
P577
2007-11-30T00:00:00Z